Aetna Inc. Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Aetna Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Aetna Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aetna Inc. | - | - | - | - | - | - | - |
| Humana Inc. | -1.790% | 3.067% | -2.326% | 46.661% | 53.005% | -25.482% | -5.379% |
| Cigna Corp. | -1.150% | -1.591% | -6.148% | 2.095% | 2.857% | -8.359% | 33.963% |
| UnitedHealth Group Inc. | 0.060% | -1.884% | -4.785% | 64.324% | 26.410% | -22.748% | 0.811% |
News
Evolent Health Q2 Earnings Call Highlights
Key Points
- Interested in Evolent Health, Inc? Here are five stocks we like better.
- Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA
CVS Health Q2 Earnings Call Highlights
Key Points
- Interested in CVS Health Corporation? Here are five stocks we like better.
- CVS Health exceeded second-quarter expectations, reporting $106 billion in revenue, adjusted EPS of $2.58
Sight Sciences Q2 Earnings Call Highlights
Key Points
- Interested in Sight Sciences, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 20% year over year to $23.4 million, driven by 8% growth in interventional